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Immune protection against pulmonary infections, such as seasonal flu and invasive pneu-
monia, is severely attenuated with age, and vaccination regimes for the elderly people
often fail to elicit effective immune response. We have previously shown that influenza
and pneumococcal vaccine responses in the older population are significantly impaired in
terms of serum antibody production, and have shown repertoire differences by CDR-H3
spectratype analysis. Here we report a detailed analysis of the B cell repertoire in response
to vaccine, including a breakdown of sequences by class and subclass. Clustering analy-
sis of high-throughput sequencing data enables us to visualize the response in terms of
expansions of clonotypes, changes in CDR-H3 characteristics, and somatic hypermutation
as well as identifying the commonly used IGH genes. We have highlighted a number of
significant age-related changes in the B cell repertoire. Interestingly, in light of the fact that
IgG is the most prevalent serum antibody and the most widely used as a correlate of pro-
tection, the most striking age-related differences are in the IgA response, with defects also
seen in the IgM repertoire. In addition there is a skewing toward IgG2 in the IgG sequences
of the older samples at all time points. This analysis illustrates the importance of antibody
classes other than IgG and has highlighted a number of areas for future consideration in
vaccine studies of the elderly.
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INTRODUCTION
Until recently the methods available to study B cell repertoire
were limited by the fact that the diversity of the repertoire was
far greater than the number of sequences that could feasibly be
studied. A random sampling of cells responding to vaccine would
pick up the most prevalent Ig genes but would not give any indi-
cation of the diversity of cells responding to challenge. In mice
the T-dependent NP response is a widely used and versatile tool
for the study of immune responses, it tends to be restricted to use
of the V186.2 heavy chain. In humans the isolation of rearranged
Ig genes with more than one type of IGHV gene has indicated
that there might be diversity in the response, but the numbers
of sequences studied in these experiments have been low. One
of the best examples of repertoire analysis was by Kolibab et al.
(2005a) who looked at approximately 1300 sequences from 40 dif-
ferent donors after immunization by the pneumococcal vaccine
and identified the major IGHV genes in use. With the advent
of high-throughput sequencing methods we can now study the
human immune response in much more detail.
A perennial problem in vaccination is that of vaccine ineffi-
ciency in older people. Vaccine-specific antibodies in older peo-
ple are quantitatively and qualitatively impaired. For example,
anti-pneumococcal polysaccharide (PPS) antibodies have lower
opsonophagocytic index and affinity in the elderly than in healthy
young adults (Kolibab et al., 2005b; Park and Nahm, 2011). Strep-
tococcus pneumoniae infection is a serious complication secondary
to influenza, and together these two diseases comprise a substan-
tial infectious burden for children aged under two, the elderly
and immunocompromised individuals (McCullers, 2006). In the
UK and many other countries, co-administration of trivalent-
influenza and pneumococcal vaccines has been recommended as
the routine immunization schedule to protect these at-risk groups.
Although influenza vaccines appear effective in most groups with
nearly 70% vaccine efficacy (Osterholm et al., 2012), less than half
of the older adults are protected by influenza vaccines (Nichol et al.,
2007). While the immunogenicity of PPS vaccines in the protein-
conjugated form (PCV) is much improved for young children,
neither PCV nor 23-valent PPS vaccine (PPV-23) is able to confer
an effective protection in the older population (Baxendale et al.,
2010).
We have previously seen that there may be changes in the selec-
tion process during affinity maturation of B cells (Banerjee et al.,
2002), and also that the B cell repertoire is often less diverse in old
age with evidence of non-pathogenic clonal expansions (Gibson
et al., 2009). This loss of diversity correlated with the health of
the individual. Further investigation as to whether loss of diver-
sity in the B cell repertoire correlated with poor vaccine responses
against influenza and pneumonia indicated that it may be a con-
tributory factor, but that other factors were likely also involved
(Ademokun et al., 2011). These two vaccines generate different
responses; influenza is believed to mainly induce IgG1/IgG3/IgA1
T-dependent responses (Brown et al., 1985; Hocart et al., 1990;
www.frontiersin.org July 2012 | Volume 3 | Article 193 | 1
Wu et al. Age and vaccination affect IGH repertoire
Powers, 1994), while pneumococcal responses are thought to be
T-independent and can lead to significant elevation of IgA2/IgG2
antibodies in the serum and mucosa (Lue et al., 1988; Carson et al.,
1995; Sanal et al., 1999; Simell et al., 2006; Benckert et al., 2011).
To investigate the diversity of the response to these vaccines in
more detail we have analyzed high-throughput sequencing data in
order to characterize the response with respect to Ig gene usage
and hypermutation whilst paying particular attention to the sub-
classes of antibodies involved. There are significant differences in
the older vaccine response with respect to class and subclass of
antibody, extent and timing of clonal expansions and focusing
of the repertoire toward Ig sequences with higher mutation and
shorter CDR-H3 regions.
MATERIALS AND METHODS
VOLUNTEERS AND SAMPLE COLLECTION
Six young (aged 19–45) and six older (aged 70–89) healthy volun-
teers were recruited as a part of the 2009/10 influenza vaccination
program in Lambeth Walk GP Practice. Blood and serum samples
were collected after obtaining written consent as approved by the
Guy’s Hospital Research ethics committee, prior to vaccination
at day 0 (D0) with the influenza (Influvac; Solvay, Southampton,
UK), and 23-valent pneumococcal (Pneumovax II; Sanofi Pas-
teur MSD, Maidenhead, UK) vaccines and post vaccination at
day 7 (D7) and day 28 (D28). PBMCs were isolated using Ficoll-
Paque Plus (GE Healthcare, Buckinghamshire, UK) in conjunction
with Leucosep tubes (Greiner Bio-One Ltd., Gloucestershire, UK),
according to manufacturer’s instructions.
TOTAL RNA EXTRACTION AND cDNA CONVERSION
Total RNA was extracted from 2× 107 PBMCs per donor per time
point using the RNeasy Mini Kit (Qiagen, UK). The SuperScript
III First-Strand cDNA Synthesis System (Invitrogen, UK) was
then used to convert RNA into cDNA according to the manufac-
turer’s protocol. In brief, a 200-µL cDNA reaction mix contained
extracted total RNA, 500 ng Oligo(dT)20, 500µM dNTPs, 400 U
RNaseOut, 10 mM DTT, and 2000 U SuperScript III RT in 1×
First-Stand RT buffer. The cDNA reaction was carried out as
follows: 65˚C for (5 min), 4˚C (60 s); 50˚C (1 h); 70˚C (15 min).
HIGH-THROUGHPUT SEQUENCING OF IgH GENES
Ig genes were isolated by semi-nested, isotype-specific PCR reac-
tions, as previously reported (Wu et al., 2010). Briefly, a 25-µL
PCR1 reaction mix contained 6.25µL of cDNA, 0.625 U Phu-
sion DNA polymerase (NEB, UK), 200µM each dNTP, 41.75 nM
each of 6 IGHV gene family primers in conjunction with 250 nM
of either IgM, pan-IgA, or pan-IgG constant region primers.
Two microliters of PCR1 products were subsequently re-amplified
using multiplex identifier (MID)-containing primers in a semi-
nested reaction consisting of 0.5 U Phusion DNA polymerase,
200µM each dNTPs, 41.75 nM each of the IGHV gene fam-
ily/MID primers, and 250 nM of the nested constant region/MID
primers in a 20-µL reaction volume. PCR conditions are as fol-
lows: 98˚C for (30 s), 15 (PCR1), or 20 (PCR2) cycles of 98˚C (10 s);
58˚C (15 s); 72˚C (45 s), and 1 cycle of 72˚C (10 min). In order to
produce sufficient quantity for high-throughput sequencing on
the GS FLX System (Roche, Germany), eight different PCR1 for
each sample, followed by 16 PCR2 (two per initial PCR1 round)
reactions were performed for each isotype. This total sampling of
cDNA was approximately equivalent to that from 2× 105 B cells.
The downstream preparation of PCR products and data processing
are as previously published (Wu et al., 2010).
DETECTION OF ANTI-PPS IgA ANTIBODIES
Serum anti-PPS IgA antibodies from immunized young (age 18–
49, n= 39) and older (age 65–89, n= 27) healthy volunteers
were measured by ELISA, as previous reported (Ademokun et al.,
2011). In brief, the 89-SF standard (Bethesda, MD, USA) or serum
samples were pre-absorbed with 10µg/mL cell wall polysaccha-
ride (CPS; Statens Serum Institute, Copenhagen, Denmark) or
10µg/mL CPS in conjunction with 10µg/mL 22F polysaccha-
ride, respectively, before being serial diluted and incubated with
microtiter plates coated with 100µL per well of a combination
of seven polysaccharide serotypes (4, 6B, 9, 14, 18C, 19F, and
23F, 1µg/mL each; ATCC, Rockville, MD, USA) overnight at
4˚C. After washing with TBS containing 0.1% Brij 35 (Sigma-
Aldrich, St. Louis, MO, USA), HRP-conjugated goat anti-human
IgA (Invitrogen) diluted at 1/4000 in PBS with 0.05% Tween-20
was added to the plates and incubated for 2 h, followed by another
2 h of incubation with TMB chromogen substrate (Invitrogen) in
diethanolamine buffer, before terminating the reaction with 3 M
NaOH. Serum anti-PPS IgA levels were read at OD 450 nM on
an ELISA microplate reader and then compared with the 89-SF
standard.
SEQUENCE ANALYSIS
Ig gene usage and CDR-H3 junction regions between the con-
served first (cysteine) and last amino acid (tryptophan) were
determined using IMGT V-QUEST (Wilkins et al., 1999). Internal
isotype motifs in the constant regions of each sequence fur-
ther identified subclasses of sequences. ProtParam was used to
determine the physicochemical properties of the CDR-H3 pep-
tide (Brochet et al., 2008). The grand average of hydropathicity
(GRAVY) and aliphatic indices are positive indicators for peptide
hydrophobicity and structural thermostability respectively (Ikai,
1980; Wilkins et al., 1999). The percentage match of each IGHV
sequence to germline gene was returned by IMGT V-QUEST, and
the level of hypermutation was calculated to be the percentage
difference from the corresponding germline gene.
The DNA sequences of the CDR-H3 were used for clonotype
clustering by a distance-matrix between all pairwise comparisons,
as previously reported (Ademokun et al., 2011). When neces-
sary, clonally related IGH sequences were aligned with putative
germline genes and edited to remove homopolymer tract errors
using DNAstar software (Laser Gene). Mutational phylogenetic
trees of the edited IGH sequences were constructed by the multi-
ple sequence alignment modes (MUSCLE 3.7) using the Phylogeny
Analysis program (Dereeper et al., 2010).
STATISTICS
Statistics were performed with GraphPad Prism 5.0. Most statisti-
cal analyses were one-way or repeated measures ANOVA (with
Bonferroni post-test) and Kruskal–Wallis comparisons (with
Dunn’s post-test). Wherever necessary, Chi-squared test (with
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Bonferroni post-test), paired t -test, and Mann–Whitney U -test
was performed. To test association between different metrics, Pear-
son correlation analysis in conjunction with linear regression was
performed.
RESULTS
IGH REPERTOIRE CHANGES IN RESPONSE TO VACCINATION
High-throughput sequencing of samples from peripheral blood
B cells in six young and six old donors in the course of vaccina-
tion produced 45,784 IGH sequences, which were grouped into
17,962 different clonotypes (i.e., a representative clone for that
particular Ig gene rearrangement, Table 1). In order to investigate
the effect of vaccination on the underlying repertoire without the
influence of in vivo and in vitro clonal expansion, only clonotypes
were included for this analysis. In general, the repertoire displayed
resilience in that at D28 post vaccination it showed similar char-
acteristics to D0 (before vaccination) despite significant changes
at day 7 post vaccination. These changes at D7 included a change
in expression of some IGHV and IGHJ genes such that signifi-
cant differences were seen in IGH gene family usage (Figure 1A).
Most notably, at D7 after vaccination there is a significant increase
in the proportion of clonotypes that use IGHV6-1, IGHV1-46,
and several IGHV3 genes with a decrease in those using IGHV2,
IGHV4 gene families, and IGHV3-21 (Figure 1B). An increased
usage of the shorter IGHJ4 genes by 4.5% with a concomitant
decrease in use of the longer IGHJ6 gene (Figure 1C; p< 0.05) at
D7 may explain the overall reduction in the CDR-H3 size by 2 nt
(Figure 1D; p< 0.0005, Kruskal–Wallis test). The D7 population
also has a more hydrophilic CDR-H3, as shown by a more nega-
tive GRAVY index (Figure 1E; p< 0.0005), and is also less aliphatic
(Figure 1F; p< 0.0005).
AGE-RELATED DIFFERENCES IN VACCINE-INDUCED CLONAL
EXPANSION
It has been shown that clonal expansion after challenge is delayed
and persists longer in old mice (Szabo et al., 2004). More recently,
Lindner et al. (2012) reported that the intestinal IgA repertoire
has fewer large, expanded, clones in old mice. In humans, we
have previously shown vaccine-induced changes in CDR-H3 size
and hydrophobicity in expanded clones of young people, but
the changes are less obvious in the older group (Ademokun
et al., 2011). Here we aim to investigate age and challenge-related
changes in IGH gene usage. To ensure that our comparative
analyses of clonal expansion reflect the effects of in vivo clonal
expansion, rather than in vitro amplification from PCR, the IGH
sequences were produced using the same number of cells in each
sample. In the overall repertoire, large clones containing up to 687
member sequences appear at D7 and are seen less frequently at D28
in the young group, whereas in the older group the largest clone
that appears at D7 has only 242 sequence members and some large
clones are also observed at D28 (Figure 2A). Intraclonal variations
in IGHV sequences indicate that these large clones likely represent
in vivo expansion (Figure 6). To understand how clonal expansion
occurs in different classes of B cells, IGH sequences were grouped
by isotype for further analyses of clone size (Figures 2B–D). Signif-
icant increases in the average clone size at D7, as result of increased
proportion of large clones, are seen in all isotypes in both age
groups, although the increase in IgM clones is not as great as that
seen in IgA and IgG clones. The pattern of vaccine responses in IgG
and IgM clones, as indicated by changes in the average clone size,
is similar between the two age groups (Figure 2B). The increase
in average clone size was usually related to the accumulation of
greater numbers of larger clone sizes, except in the case of IgA,
where the young and old samples had comparable numbers of
clones larger than 3, but the average clone size in young IgA clones
at D7 is twice that of the old clones at D7 (Figure 2B; p< 0.005)
This implies that the IgA clones in the young are larger than in the
old. Consistent with this, the largest clones at D7 in the young in
Figure 2A were IgA. Interestingly, the clone size is 2.5-fold larger
in old IgA clones at D28 as compared with the young (Figure 2B;
p< 0.005), and is larger than it was in the old at D7. So there may
be a more delayed clonal expansion in IgA cells with age; while the
young showed expansion at D7 and contraction back to D0 levels
at D28, the level of expansion in the old may not yet have reached
a peak by D28.
The vaccine response at D7 is very diverse at all ages in that
changes in the average clone size are not restricted to particular
IGHV family IGHJ gene combinations (Figure 2C). We calculated
the fold difference in clone size between D7/D0 and D28/D7 for
individual IGHV genes. At D7 there were 24 different IGHV genes
of the IgA isotype and 16 different IGHV genes of the IgG isotype
that had more than twofold increases in their average clone size
Table 1 | Numbers of IGH sequence and clonotypes produced by high-throughput sequencing.
Ages Days IgA IgG IgM Unknown3 Total
Young (6 donors) D0 8861/14242 1035/1651 847/1208 413/737 3181/5020
D7 976/5922 717/2707 641/1214 4912750 2825/12593
D28 1070/1777 1298/2085 1036/1280 626/1059 4030/6201
Old (6 donors) D0 928/1747 675/1528 809/1109 474/1175 2886/5559
D7 644/1994 988/3801 579/998 418/1825 2629/8618
D28 1223/5099 475/901 322/400 391/1393 2411/7793
1The numbers of clonotypes refer to unique sequences, where only one example of a clonal expansion is counted after CDR-H3 clonotype clustering.
2The numbers of IGH sequences, generated from approximately 2×105 B cells per sample, represent those that passed quality control with full immunoglobulin VDJ
gene rearrangement.
3Unknown isotype refers to sequences that do not extend far enough to the constant region for isotype identification.
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FIGURE 1 |Vaccine-induced changes in the overall IGH clonotype
repertoire. IGH genes in each sequence were analyzed by IMGT
V-QUEST and then clustered into clones by CDR-H3 DNA sequence
similarity. Only one sequence example per clone was chosen to
represent its clonotype. The relative frequency (y -axis) of all clonotypes
(IgA, IgG, and IgM combined) by (A) IGHV gene family, (B) individual
IGHV gene, and (C) IGHJ gene usage (x -axis) was calculated for six
young (squares) and six old (triangles) donors individually before being
grouped as a whole cohort of 12 donors for repeated measures ANOVA
comparison between D0 (open bars), D7 (red bars) and D28 (grey bars).
Bars indicate MEAN. (D) CDR-H3 virtual spectratypes, showing the
relative frequency (y -axis) of a particular CDR-H3 size (x -axis in amino
acid numbers) within the whole CDR-H3 repertoire, was calculated
using all clonotypes from 12 donors at D0 (dotted line), D7 (red bars),
and D28 (solid line). The GRAVY and aliphatic indices for each CDR-H3
peptide was determined by ProtParam. The overall GRAVY (E) and
aliphatic (F) indices all clonotypes from 12 donors were compared by
Kruskal–Wallis comparisons with Dunn’s post-test between D0
(squares), D7 (circles), and D28 (diamonds). Error bars indicate ±SEM.
*p<0.05, **p<0.005, and ***p<0.0005.
(Figure 2D). The above age-related differences in the average clone
size for IgA clones at D7 and D28 (Figure 2B) are a reflection of
a diverse response, involving many different IGHV family IGHJ
combinations and individual IGHV genes rather than any partic-
ular IGH genes (Figures 2C,D). The changes in the average clone
size and serum anti-PPS IgA antibodies at D7 from D0 were also
negatively correlated with age (Figures 2E,F).
AGE-RELATED DIFFERENCES IN CDR-H3 CHARACTERISTICS OF
EXPANDED CLONES
CDR-H3 regions have been regarded as indispensible Ig structures
for antigen recognition, therefore alterations in the physiochem-
ical properties of CDR-H3 peptides could potentially affect BCR
binding ability and selection and expansion of antigen specific cells
within a population may be detectable by changes in the CDR-
H3 characteristics (Romero-Steiner et al., 1999; Kolibab et al.,
2005b; Park and Nahm, 2011). We therefore compared CDR-H3
characteristics in IGH sequences from clones of different sizes at
D7 after challenge. The clonotypes were divided into those seen
four or less times in the sample (small clones) and those seen
five or more times (large clones). The overall hydrophobicity and
aliphatic index of CDR-H3 regions from large clones does not
significantly differ between ages when all isotypes are considered
together (data not shown). However, there are significant age-
related changes in CDR-H3 size in IgA and IgM clonotypes from
large clones (Figure 3A) that was not seen in IgG clonotypes (data
not shown). IgM clonotypes show significantly larger CDR-H3
sizes in all clones regardless of clone size in the old samples than
in the young at both D0 and D7 (Figure 3A). The differences in
the CDR-H3 size are mainly due to an increase in the total length
of IGHD genes (Figure 3B), not IGHJ (data not shown), and an
increase in the numbers of N-nucleotides that reaches significance
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FIGURE 2 | Age-related differences in clonal expansion and serum
anti-PPS IgA antibodies after vaccination.The size of each clone was
determined. (A)The relative proportion (y -axis; %) of clones of different sizes
(x -axis) was calculated using a collection of total clonotypes (IgA+ IgG+ IgM)
from six young and six old donors at D0 (blue bars), D7 (red bars), and D28
(green bars). (B) Clonotypes were grouped by isotype and size (clone size=1
and 2 in blue bars, 3 and 4 in grey bars; 5 and above in green bars; Left y -axis
in %), and the proportion of each group was calculated for six young and six
old donors at D0, D7, and D28. The average clone size (red line; Right y -axis)
was calculated for each donor individually to be the ratio of total sequence
numbers to total clonotype numbers, before being compared between
different days (*p<0.05 and ***p<0.0005; repeated measures ANOVA
comparison) or between ages (†p<0.005; one-way ANOVA comparisons).
Bars indicate ±SEM. (C) IgA and IgG clonotypes from six young and six old
donors at different days were grouped by IGHV family (x -axis) and IGHJ
(z -axis) gene usage, and the average clone size (y -axis) for each group was
calculated. (D) IgA and IgG clonotypes from six young (Y) and
(Continued)
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FIGURE 2 | Continued
six old (O) donors at different days were grouped by individual IGHV gene
usage, and the average clone size for each group was calculated. The fold
change of the average clone size at D0 from D7 (D7/D0) and at D28 from D7
(D28/D7) was calculated and is shown by different colors (grey as unchanged,
green as fold decrease and red as fold increase). Serum levels of IgA
antibodies specific for seven serotypes combined were determined using
ELISA. Pearson correlation analysis was used to test the correlative
relationship of age (x -axis in years) with changes in (E) serum anti-PPS IgA
antibodies (n=66) and (F) the average clone size (D7-D0, n= 12), r 2 and p
values indicated. The Goodness-of-Fit (solid lines) was analyzed by linear
regression with 95% CI indicated (dashed lines).
in expanded large clones (Figure 3C). There is also a significant
age-related increase in the CDR-H3 size and CDR-H3 compo-
nents in IgA clonotypes, although this is restricted to D7 and D28
post-challenge and is mainly in the larger clones (Figures 3A–C).
AGE- AND CHALLENGE-RELATED CHANGES IN HYPERMUTATION
Since the level of hypermutation accumulated in the Ig variable
region often reflects the history of affinity maturation in B cell
clones specific for a particular type of antigen, we compared IGHV
mutation levels over the course of vaccination and in different age
groups. The average mutation frequency is significantly increased
in IgM clonotypes from both age groups at D7 after vaccina-
tion (Figure 4A), although the change at D7 from D0 in old IgM
clones was threefold smaller than that in the young. Changes in
overall IGHV mutation levels in IgM clones in response to vac-
cines and with age can also be demonstrated by the proportional
alteration between unmutated versus heavily mutated IgM clones
(Figures 4B,C).
A higher mutational frequency is observed with age in IgG
clonotypes at all time points (p= 0.0003, Mann–Whitney U -
test; data not shown). We did not see an increase in the overall
mutation levels in IgA clonotypes after challenge in either age
group (data not shown). Since IgA populations are reflective
of prior challenge and hypermutation this perhaps would not
be expected. However, looking solely at the large clones (five
sequences or more per clone), presumably enriched for the ones
responding to vaccination as opposed to those that were histori-
cally mutated, we saw that IgA clonotypes from old donors had a
lower average frequency of mutation than the young (p= 0.0025,
Mann–Whitney U -test). This may be due to the reduction in
the proportion of heavily mutated, large IgA clonotypes with age
(Figures 4D,E). A similar trend is also observed in IgM clonotypes
(Figure 4F).
AGE AND CHALLENGE-RELATED CHANGES IN CLONOTYPES AND
CLONAL EXPANSION BY IGH SUBCLASS
We previously reported that isotype-switched and innate-like
IgM+memory cells have distinct IGHV repertoires, and later that
there are some similarities between the innate-like IgM+ mem-
ory cell repertoire and that of IgG2 and (to a lesser extent) IgA2
memory cells. Therefore we proposed that a large proportion of
IgG2 and IgM (and possibly IgA2) memory cells may be subject
to a different selection process from that imposed on other classes
and subclasses of memory cells (Wu et al., 2010, 2011). In order
to compare the vaccine response in B cells of different subclasses
we stratified the overall clonotype repertoire by subclass. This was
done by searching for subclass-specific motifs upstream of the
pan-IgA or pan-IgG primer sequences, so that any difference in
subclass within a particular class is not due to a difference in primer
binding efficiency. In line with previous reports (Wu et al., 2010,
2011), over-representation of IGHV3 and under-representation of
IGHV1 genes are seen in IgM, IgG2, and IgA2 clonotypes in both
age groups at all time points analyzed when compared to IgG1,
IgG3, and IgA1 clonotypes (data not shown). Within the IgA and
IgG compartments the proportions of the subclasses vary with
challenge, with a significant increase in the proportion of IgA2
and IgG2 clonotypes being seen in both age groups at D7 com-
pared to D0 (Figure 5A; p< 0.005, repeated measures ANOVA).
Although we failed to detect any age-related differences in Ig gene
usage in IgA and IgG subclasses (data not shown), there is a sig-
nificant difference in IgG subclass distribution with age at both
D0 and D7, with the older group having an increased propor-
tion of IgG2 compared with the young (Figure 5A; p< 0.0005,
Mann–Whitney U -test). The increased proportion of IgA2 and
IgG2 subclasses after vaccination are also observed when clone
relatives (i.e., all sequences not just clonotypes) are included for
analysis (Figure 5B).
FIGURE 3 | Age-related changes in CDR-H3 characteristics from
clonotypes in different sizes. IMGT V-QUEST was used to determine
the size of the CDR-H3 region and its components, i.e., N-nucleotide
numbers and IGHD genes, in each IGH sequence. After clustered by
CDR-H3 sequence motifs, IgM, and IgA clonotypes were sorted by
clone sizes. (A)The mean size of CDR-H3 regions (in amino acids),
(B) the mean length of overall IGHD genes (in nucleotides), and (C) the
mean number of N-nucleotides from all clonotypes (A), clonotypes ≤4
(S) and clonotypes ≥5 in size (L) were compared between six young
(square) and six old (triangle) donors at D0, D7, and D28, using
Mann–Whitney U-tests (*p<0.05, **p<0.005, and ***p<0.0005).
Error bars indicate ±SEM.
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FIGURE 4 |Vaccine-induced changes in IGHV mutations. (A)The
frequency of IGHV mutations in each sequence was calculated to be the
percentage difference from germline identity, determined by IMGT
V-QUEST. Kruskal–Wallis comparisons were used to compare the mean
IGHV mutation between IgM clonotypes from six young (squares) and six
old (triangle) donors (age-related differences: ‡<0.0005) and between D0,
D7, and D28 (temporal differences:*p<0.05, **p<0.005, and
***p<0.0005, as compared with D7). Error bars indicate ±SEM. All IgM
clonotypes were grouped by the level of IGHV mutation and the
proportion of each group was compared using Chi-squared tests between
days (D0: inner circles, D7: middle circles, and D28: outer circles;
*p< 0.05, **p<0.005, and ***p<0.0005) and between six young (B)
and six old (C) donors [†p<0.05 and ‡p< 0.005, as indicated in (C)]. For
clones ≥5 in size, IgM clonotypes at D7 (D), IgA clonotypes at D7 (E), and
IgA clonotypes at D28 (F) were grouped by the level of IGHV mutations
and the proportion of each group was compared between six young (outer
circles) and six old (inner circles) donors, using Chi-squared tests
(*p<0.05).
Generally the differences in clonotype subclass distribution
(Figure 5A) are mirrored in sequence subclass distribution
(Figure 5B). However, in IgG there appears to be a greater bias
toward IgG2 in sequences compared to clonotypes, indicating that
in the young the IgG2 clonotypes belong to larger clones. Dif-
ferences in IgA and IgG average clone size at the different time
points are shown in Figures 5C,E respectively, with details of the
distribution of clones in the different subclasses in Figures 5D,F.
Significant age-related differences in the average IgA clone size
(Figure 2B) are seen at D7 and D28, and appear to be mainly due
to the IgA1 subclass having a smaller clone size at D7 but bigger at
D28 in the old as compared with the young (Figure 5C). Although
the average clone size in IgA2 does not seem to change with age,
more detailed analysis of IgA2 clone size distribution shows that
the frequency of large clones, containing over 20 sequence mem-
bers, is lower at D7 (p= 0.002; Chi-squared test) but higher at D28
in old repertoires, as compared with the young (Figure 5E). In
both age groups the average clone size of IgG2 is significantly big-
ger than IgG1 at D7 (p= 0.0008, paired t -test; Figure 5D). Thus, in
addition to there being an increase in the number of different IgG2
clonotypes in the sampled repertoire at D7, the individual IgG2
clonotypes are expanded more than IgG1 clonotypes. The age-
related increase in the proportion of IgG2 clonotypes at D7 and
D28 (Figure 5A) is not accompanied by any significant difference
in the clone size (Figure 5D). So although the older repertoire has
a greater representation of IgG2 sequences these are not expanded
any more than in the younger group. The IgG1 and IgG2 clone
distribution is illustrated in more detail in Figure 5F.
CLONAL EXPANSION AS A RESULT OF RECALL IMMUNE RESPONSES
Previous studies show that influenza-specific cells (Wrammert
et al., 2008) and anti-PPS plasma cells (Baxendale et al., 2010)
can be detected in the serum prior to vaccination and their fre-
quencies are increased at D7 following vaccination. Although our
sequences were produced using unsorted PBMCs, large sequence
numbers allowed us to track responding clones sampled at D7
back to their clone relatives sampled at D0 prior to vaccina-
tion, using mutational phylogeny analysis (Dereeper et al., 2010).
We find a total of 648 different clonotypes (3.6% of all clono-
types) containing clonally related IGH sequences that represent
cells sampled at different days (Table 2). 71% of these clones are
of a single isotype, being significantly more frequent than those
having IGHM sequences related to IGHG and IGHA sequences
(12.8%; Chi-squared test, p< 0.0001). As expected, the propor-
tion of clonotypes that share sequences across different time points
increases to 20%, when only large clones are considered (Table 2).
Out of these larger clones, 57 clonotypes (4.6%) contain IGH
sequences that have already switched to IgA and IgG isotypes at
D0 prior to vaccination (Figure 6A), suggesting a recall immune
response by pre-existing memory B cells. Similarly, there are also
clones that contain mutated IgM+ sequences at D0 (Figure 6B).
Mutational phylogenetic trees show great diversification within
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FIGURE 5 | Age and challenge-related changes in IGH subclass.
Internal motifs in the constant region were used to identify subclasses
(IgA1, IgA2, IgG1, IgG2, IgG3, and IgG4) in each IGH sequence. The
proportion (y -axis) of clonotypes clustered by CDR-H3 (A) and total
sequences (B) of different IgA or IgG subclasses at D0, D7, and D28 was
calculated for each donor individually before being collectively analyzed
(temporal differences: ***p<0.0005 using repeated measures ANOVA
when compared with D7; age-related differences: ‡p<0.005 using
Mann–Whitney U-tests). Error bars indicate ±SEM. The average clone
size (y -axis) of IgA1 and IgA2 clonotypes (C) and IgG1 and IgG2
clonotypes (D) was calculated to be the ratio of total sequences over
total clonotypes for each donor individually, before being compared
between young versus old ages (*p<0.05; one-way ANOVA
comparison). Bars indicate ±SEM. Clonotypes of (E) IgA subclasses
(IgA1: blue bars and IgA2: red bars) and (F) IgG subclasses (IgG1: blue
bars and IgG2: red bars) were grouped by their clone sizes (x -axis), and
the proportion of each groups (y -axis) was calculated at D0, D7, and D28.
Clones containing fewer than five sequences are not shown.
expanded clones. Interestingly we also observe that sequences
sampled at D0 do not always appear less mutated than those at
D7 and D28. Similarly, IGHM sequences do not always appear
before IGHA/IGHG sequences in the lineage tree. These obser-
vations have important consequences for future interpretation of
data based on analysis of phylogenetic trees.
DISCUSSION
Improving the immunogenicity of vaccines against S. pneumoniae
and influenza in the older person is a challenge (Artz et al., 2003;
Hannoun et al., 2004). Effective antibody production is impaired
in older people but the exact causes of this impairment have
not been fully elucidated. An earlier study showed that affinity
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Table 2 | Numbers of clones with clonality between IGH sequences sampled at different days1.
All clonotypes2
Day1 Old (n=79263; 6 donors) Young (n=97743; 6 donors)
ISO5 AG AGM AM GM Single6 AG AGM AM GM Single
0 and 28 3 1 1 1 94 17 0 3 7 94
0 and 7 4 3 7 4 47 8 3 20 1 38
0 and 7 and 28 4 1 2 0 16 5 3 2 0 4
7 and 28 23 4 3 3 93 38 6 8 0 77
Clonotypes ≥5 in size
Day Old (n=6714; 6 donors) Young (n=5724; 6 donors)
ISO AG AGM AM GM Single AG AGM AM GM Single
0 and 28 1 1 25 11 0 0 1 22
0 and 7 3 3 1 1 19 5 2 13 1 9
0 and 7 and 28 4 1 1 0 12 4 3 1 0 2
7 and 28 20 4 2 0 36 32 6 3 0 24
1CDR-H3 sequence motifs are used to identify clones containing IGH sequences that that have the same VDJ rearrangement but are sampled at Day 0, 7, and 28.
2All clonotype refers to all clones in various sizes.
3Numbers refers to all clonotypes produced by high-throughput sequencing.
4Numbers refer to clonotypes ≥5 in size produced by high-throughput sequencing.
5Iso refers to clones containing IGH sequences sharing the same CDR-H3 region but are of different isotypes (A for IgA, G for IgG, and M for IgM).
6Single refer to clones containing IGH sequences of only one isotype.
selection in the germinal center may be altered with age, this may
be partly due to lack of appropriate help, for example from T cells,
as well as intrinsic differences in the B cell affecting its ability to
express AID (Banerjee et al., 2002; Frasca et al., 2008). We later
showed that B cell diversity decreases with age and is associated
with poor health (Gibson et al., 2009). Kolibab et al. (2005a) also
suggest that changes in Ig gene usage may account for the different
affinity of vaccine-specific antibodies between young and older
populations. Thus there may be a causal relationship between the
distortion of B cell repertoires and vaccine hypo-responsiveness
with age. However, previous repertoire analyses to investigate sim-
ilar subjects are restricted to certain genes and isotypes due to
the small numbers of sequences available (Kolibab et al., 2005a;
Smithson et al., 2005).
We have performed high-throughput sequence analysis of IGH
repertoires in human peripheral blood in order to investigate B
cell responses following vaccination with the pneumococcal and
influenza vaccines. In contrast to the oligoclonal response previ-
ously reported in response to the pneumococcal vaccine (Zhou
et al., 2004; Kolibab et al., 2005a), here we report a very diverse
and resilient vaccine response, with increased clone sizes at D7
and normal repertoire resumed at D28 (Figures 2 and 5). The
discrepancy in diversity with previous reports may reflect the
number of sequences analyzed and/or the fact that the influenza
vaccine was included in this study in addition to the pneumococ-
cal vaccine. Since the peak of the plasmablast response is generally
between days 6 and 8 (Cox et al., 1994; Wrammert et al., 2008),
and plasma cells and plasmablasts have many more copies of
immunoglobulin RNA per cell than B cells (Kuo et al., 2007),
it is reasonable to assume that the clonal expansions seen at D7
represent the cells that are responding to vaccine. We can also
see vaccine-induced changes in the CDR-H3 repertoire despite
the fact that there are a large number of different antigens in
this challenge. We previously showed that memory B cells in gen-
eral have shorter CDR-H3 regions that are more hydrophilic (Wu
et al., 2010), implying that Ig genes with these characteristics are
preferentially selected in many different responses. These changes
are also seen at D7 here (Figures 1E,F) and these data together
strongly imply that the antibody immune response to challenge is
skewed toward antibodies with certain characteristics of the anti-
gen binding region even though the antigens themselves can be
quite variable.
Many studies use specific serum IgG levels as a correlate of
vaccine protection, although this metric is not always the best
indicator. There are no age-related differences in anti-PPS IgG
serology, but there is a significant age-related decrease in serum
antibody function as determined by the opsonophagocytic assay
(Anttila et al., 1999). Recent evidence suggests that this is due to
a decrease in IgM antibody, since depletion of IgM from serum
results in decreased opsonophagocytic activity (Park and Nahm,
2011; Sasaki et al., 2011). Our repertoire analysis does not show
any age-related changes in IgG, except for a higher mutational
frequency in the older group that is likely due to longer prior
exposures to challenge with age. Nor do we see any significant
age-related differences in the level of clonal expansion of IgM
sequences. We do, however, see significant age-related differences
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FIGURE 6 | Rooted phylograms show clonally related IGH sequences
sampled at different days. CDR-H3 sequence motifs were used to identify
clone relatives of IGH sequences found across D0, D7, and D28. After editing
and aligning IGH sequences with germline gene using DNAstar software,
mutational phylogenetic trees were generated using the online Phylogeny
Analysis program (Dereeper et al., 2010). Leaves represent IGH sequences
sampled at different days (D0: red diamonds, D7: black squares, and D28:
blue circles), and the putative germline (GL) genes are indicated at the base of
trees in green. The class (IgG, IgA, and IgM) or subclass (indicated by
numbers) of IGH genes is indicated in the shapes. Internal nodes represent
hypothetical intermediates of IGH sequences, and the branch lengths indicate
percentage mutation differences between IGH sequences in proportion to
the distance scale. Only two illustrations of phylogenetic trees are shown (A)
from an old donor aged 71 years and (B) from a young donor aged 22 years.
For space consideration, sequences in the two clones are randomly chosen
for illustration.
in the CDR-H3 characteristics (Figure 4) and levels of mutation
in the IgM repertoire (Figure 3), with generally less mutation and
longer CDR-H3 in the old (both these factors being more char-
acteristic of naïve B cell repertoires rather than memory B cell
repertoires). The differences were significant at all time points so
may not necessarily be confined to a change in the response. The
IgM repertoire includes the naïve B cell population as well as IgM
memory cells, so a change in the proportions of these two popu-
lations would also have an effect on our repertoire observations;
thus, a decrease in IgM memory cells such as has been previously
suggested may account for some difference (Shi et al., 2005). How-
ever, both age groups did show an increased level of mutation at
D7 and a decrease at D28, although to a lesser extent in the old
group. In order to look at the differences between age groups in the
response without the background of naïve cells we split the data
to look at sequences that were part of large clones in isolation,
on the assumption that if a clone has expanded it is part of the
IgM memory response rather than the naïve B cells in the back-
ground. The older IgM response repertoire had longer CDR-H3
and less mutation (Figures 3 and 4), which would strongly suggest
that there is an age-related defect in the normal mechanisms of
selection and hypermutation in IgM memory. We do not know
what the specificity of these expanded IgM clones is, although
based on previous literature we would hypothesize that they are
T-independent responders to the polysaccharide antigen (Lortan
et al., 1992). IgG2 antibodies are also thought to respond to T-
independent polysaccharide antigens (Lortan et al., 1992) so it is
interesting that alongside the defect in IgM memory repertoire
there is a skewing in favor of IgG2 use in the IgG repertoire of
older people.
A role for IgA in the protective vaccine response against
influenza and pneumonia has not previously been highlighted,
and the removal of IgA from serum was not shown to have any
effect on the opsonophagocytic capability of post-vaccine serum.
Since these respiratory diseases originate at mucosal surfaces it
would seem plausible that IgA has some vital function, even if
not in the circulation. It is clear from our data that there are
significant differences in the IgA response in older people. In a
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similar manner to the IgM memory cells there is less hypermuta-
tion in the expanded clones and they have larger CDR-H3 regions.
The degree of clonal expansion is less overall and takes much
longer, to the extent that is still appears to be occurring at D28
after the younger group has contracted the response. The IgA
serum antibody response is short lived. In contrast to IgG and
IgM antibodies, which increase in serum with maximum values at
D28, the maximal serum level of IgA is at D7 in the normal young
population and it decreases by D28 (Ademokun et al., 2011). The
clonal expansions of all three isotypes peaks at D7 and contracts
at D28 in the blood (Figure 2B). Thus for IgG and IgM one can
envisage a scenario where cells have left the blood to reside in a
niche where they continue to secrete antibody into the circulation.
However the serum IgA antibody concentration seems to mirror
the clonal expansion data, which may indicate that the cells are
short lived and do not go on to secrete antibody in survival niches,
or perhaps they do survive but secrete IgA antibody at mucosal
surfaces rather than into the circulation.
Since the most striking age-related difference in these data was
in the IgA response we split the data into IgA1 and IgA2 sequences.
IgA1 has previously been associated with serum responses and
IgA2 with mucosal responses (Russell et al., 1992). It is clear
from our lineage tree analysis that IgA1 and IgA2 can be quite
closely related, since we find many clones containing both sub-
classes (Figure 6). However in Figure 5C we see that the main
age-related difference in clonal expansions that we saw at D7 and
D28 is mainly due to IgA1 rather than IgA2, and we also find clones
which do not mix the subclasses, so it is possible that certain types
of antigens/responses may elicit one subclass only.
The existence of many clones with relatives in both pre- and
post-vaccination samples (Table 2) indicates that some of these
clones may be very large even before vaccination. The chances of
finding a particular clonotype in a sample are dependent on the
number of cells sampled, the total number of cells in the blood,
and the total number of clone members in the blood. We would
not expect to find a particular clonotype more than once if it were
not part of an expanded clone. In the simplest terms, if we assume
that there are 108 B cells in the blood, and we have found two
related sequences in a sample of 5000, then there could be approx-
imately (108/5000)2, or 40,000, related sequences in that one clone
in the blood altogether. Also, if we assume that an expansion at
D7 originated from a single unique precursor in the blood at D0,
the chances of sampling and sequencing that precursor would be
1 in 108. Since we see nearly 400 examples of clones where there
are related sequences at D0 then we can provisionally conclude
that many expanded precursors of cells with specificity for these
vaccines are already present in the blood pre-challenge. Whether
these pre-existing specificities are mono-specific for the antigens
in the vaccine or are cross-reactive from a prior, related, chal-
lenge cannot be determined since it was impossible to determine
the prior extent of exposure to influenza or S. pneumoniae in the
participants. These high-throughput data have also shown that we
need to be careful about interpretation of lineage trees with respect
to inference of chronological ordering since the trees can be quite
complex (Figure 6). If there has been extensive prior expansion of
cells in the blood it cannot be assumed that all clones in the expan-
sion will have mutated at the same rate or in the same reaction.
Hence a random sampling will not always result in the samples
from the earlier time points appearing at the top of the lineage
trees (i.e., with less mutations from germline). Similarly, extensive
expansion followed by random switching and sampling may result
in a seemingly impossible succession of switching events, such
as IGHM sequences appearing downstream of IGHA sequences.
However this could simply mean that a cell has expanded without
mutation, 50% of them have switched and the sampling has picked
up one of the switched parents together with offspring of one of
the unswitched parents.
In conclusion, our high-throughput IGH repertoire analyses
have demonstrated that we can visualize an immune response
to vaccine by the expansion of clonotypes expressing particular
Ig genes, and with particular CDR-H3 characteristics. The large
clonal expansions indicate a complex recall response. There are
significant age-related differences in the response with respect to
subclass distribution, particularly in the extent and timing of IgA
clonal expansion and skewing toward greater use of IgG2. Older
responding IgM and IgA clonotypes are also less mutated and use a
longer CDR-H3, which might affect antigen recognition. Although
much more now needs to be done to explore the significance of
the age-related changes in IgA responses described here, our work
does highlight the critical need to consider different classes and
subclasses of antibody in vaccine studies in general.
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